Why the study?
Acute ischaemic strokes occur despite direct oral anticoagulant use, prompting an assessment of the acute management of stroke presentations in patients prescribed DOACs.
How are acute stroke presentations managed in patients prescribed DOACs?
How are acute stroke presentations managed in patients prescribed DOACs?
In a single-center retrospective review, DOAC plasma level assays were rarely performed and rarely influenced thrombolysis decisions in anticoagulated patients presenting with acute stroke.
No takes yet. Share an insight, caveat, or question.
Low assay adoption in DOAC-treated stroke signals implementation gaps; leaves open the utility of routine testing for thrombolysis decisions.
Teow et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: